Search

everythinglearnresearchcommunity

for

Search:↓

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PCOS can cause unusual symptoms like late puberty and enlarged clitoris, making diagnosis difficult.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Alopecia patients have less GPER-1, which might affect hair loss.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.